Outcomes of laparoscopic common bile duct exploration (LCBDE) after failed endoscopic retrograde cholangiopancreatography versus primary LCBDE for managing cholecystocholedocholithiasisopen access
- Authors
- Kim, Hanbaro; Shin, Suk Pyo; Hwang, Ji Woong; Lee, Jung Woo
- Issue Date
- Oct-2020
- Publisher
- SAGE PUBLICATIONS LTD
- Keywords
- Common bile duct stone; exploration; endoscopic retrograde cholangiopancreatography failure; laparoscopic cholecystectomy; cholecystocholedocholithiasis; stone clearance rate
- Citation
- JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, v.48, no.10
- Journal Title
- JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Volume
- 48
- Number
- 10
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74034
- DOI
- 10.1177/0300060520957560
- ISSN
- 0300-0605
1473-2300
- Abstract
- Objective This study was performed to compare the outcomes of laparoscopic common bile duct exploration (LCBDE) after failed endoscopic retrograde cholangiopancreatography (ERCP) versus primary LCBDE for managing cholecystocholedocholithiasis. Methods We retrospectively analyzed data from 59 patients who underwent LCBDE during laparoscopic cholecystectomy (LC) for managing cholecystocholedocholithiasis from January 2013 to August 2019. The patients underwent either primary LCBDE plus LC (Group I) or LCBDE plus LC after failed ERCP (Group II). The demographics, reason for ERCP failure, perioperative details, and postoperative outcomes were evaluated. Results CBD stone removal using preoperative ERCP failed in 31 patients (Group II) because of remaining stones after ERCP (n = 9), failed cannulation (n = 6), failed sedation (n = 6), a periampullary diverticulum (n = 5), previous Billroth II gastrectomy (n = 3), a huge stone (n = 1), and an impacted stone (n = 1). The CBD stone clearance rate was >96% in both groups. The mean operative time, hospital stay, overall complication rate, and open conversion rate were not significantly different between the two groups. Conclusions When extraction of CBD stones by ERCP is likely to be difficult or fail, primary LCBDE is an acceptable alternative treatment for managing cholecystocholedocholithiasis.
- Files in This Item
-
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74034)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.